In a trial of men with metastatic prostate cancer, initial - TopicsExpress



          

In a trial of men with metastatic prostate cancer, initial treatment with hormonal therapy plus chemotherapy with docetaxel improved survival to a greater extent than hormonal therapy alone. UpToDate recommends this combination therapy for men with prostate cancer who have not previously received hormonal therapy and have substantial metastatic disease. For related UpToDate “What’s New” content and the supporting evidence click here:
Posted on: Tue, 17 Jun 2014 16:15:06 +0000

Recently Viewed Topics




© 2015